Efficiency of endovascular treatment in patients of superior Vena cava syndrome

Key Findings & Data:Although radiotherapy and/or chemotherapy are recommended as first step for the treatment of malignity-related SVCS, use of endovascular treatment methods recently more important strategy since it leads to disappearance of symptoms in a short time and increase in life quality.

💡

Conclusion & Impact:The mean Kishi's score decreased from 5.67+1.23 to 1.33±0.88 and the difference was statistically sig¬nificant (p

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

The superior vena cava syndrome (SVCS) is usually associated with advanced malignancy. Although radiotherapy and/or chemotherapy are recommended as first step for the treatment of malignity-related SVCS, use of endovascular treatment methods recently more important strategy since it leads to disappearance of symptoms in a short time and increase in life quality. The aim of this study was to evaluate the endovascular treatment of superior vena cava obstruction secondary to malignant disease among twelve patients who were diagnosed at Medical Oncology, Thorax Disease and Radiology Departments of Uludağ University Medical Faculty. The diagnosis of malignancy was small cell lung carcinoma (n:4), non small cell lung carcinoma (n:7) and mesothelioma (n:l). Self expandable nitinol type stents were used in all patients. The evaluation of the symptoms before and after the procedure was assessed according to Kishi's score. The mean Kishi's score decreased from 5.67+1.23 to 1.33±0.88 and the difference was statistically sig¬nificant (p

Özet

Vena kava superior sendromu (VKSS), genellikle ileri dönemdeki malign hastalıklara bağlı olarak gelişir. Maligniteye bağlı VKSS tedavisinde ilk basamak olarak radyoterapi ve/veya kemoterapi önerilmekle beraber semptom¬ları kısa zamanda gidermesi ve hayat kalitesini hızla düzeltmesi nedeniyle endovasküler tedavi yöntemleri giderek güncellik kazanmaktadır. Çalışmamıza Uludağ Üniversitesi Tıp Fakültesi Medikal Onkoloji ve Göğüs Hastalıkları Anabilim Dalı'na başvuran ve tanı aldıktan sonra Radyoloji Bilim Dalı'na yönlendirilen VKSS tanılı 12 hastada endovasküler tedavi sonuçları değerlendirildi. Histopatolojik inceleme sonucu hastaların 4'ü küçük hücreli akciğer kanseri, 7'si küçük hücreli olmayan akciğer kanseri, l'i mezotelyoma idi. Tüm hastalara self expandable nitinol tip stent uygulandı. Semptomların şiddet değişiklikleri işlem öncesi ve sonrası Kishi skorlamasına göre değerlendirildi. Kishi skoru, işlem öncesi ortalama 5.67±1.23 iken işlem sonrasında 1.33±0.88 olarak saptandı. Aradaki fark istatiksel açıdan anlamlı bulundu (p

🔖

Cite This Article

KURT, E., MANAVOĞLU, O., EVRENSEL, T., GÖNÜLLÜ, G., KANAT, Ö., DEMİRAY, M., GÖZKAMAN, A., ARSLAN, M., URSAVAŞ, A., ERDOĞAN, C. (2022). Efficiency of endovascular treatment in patients of superior Vena cava syndrome. Bursa Devlet Hastanesi Bülteni, Cilt: 19 - Sayı: 3, 139–143. https://ajindex.com/articles/469454

References (15)

Yim CD, Sane SS, Bjarnason H: Superior vena cava stenting. Radiol Clin North Am 38: 409-23, 2000
Schindler N, Vogelzang RLSuperior vena cava syndrome (Eds. Pearce WH, Matsumura JS, Yao JT). Surgical Clinics of North America. WB.Sounders Company, Pennsylvania. 1999, pp 683-94
Qanadli S, El-Hajjam M, Mignon F, Kerviler E, Rocha P, Bar-re Q, Chagnon S, Lacombe P: Subacute and chronic benign superior vena cava obstructions. AJR 173:154-64, 1999
Comerota AJ: Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. Chest 99: 3-4,1991
Gray BH, Olin JW, Graor RA, Young JR, Bartholomew JR, Ruschhaupt WF: Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. Chşst 99: 54-9, 1991
Kishi K, Sonomura T, Mitsuzane K, Nishida N, Yang Rj, Sato M, Yamada R, Shirai S, Kobayashi H: Self-expandable metallic stent therapy for superior vena cava syndrome: Clinical observations. Radiol 189: 531-5,1993
Chen JC, Bongard F, Klein SR: A contemporary perspective on superior vena cava syndrome. Am J Surg 160: 207-11, 1990
Marcy PY, Magne N, Bentollia F, Drouillard J, Bruneton JN, Descamps B: Superior vena cava obstruction is stenting necessary? Support Care Cancer 9:103-7, 2001
Davenport D, Ferree C, Blake D, Raben M: Radiation therapy in the treatment of superior vena cava obstruction. Cancer 42:2600-3,1978
Kane RC, Cohen MH: Superior vena caval obstruction due to small-cell anaplastic lung carcinoma. Response to chemotherapy. JAMA 235:1717-8, 1976
Charnsongavej C, Carrasco CH, Wallace S, Wright KC, Ogawa K, Richli W, Gionturco C: Stenosis of the vena cava: Preliminary assessment of treatment with expandaple metallic stents. Radiol 161:295-8,1986
Spiro SG, Shah S, Harper PG, Tobias JS, Geddes DM, Souhami RL: Treatment of obstruction of the superior vena cava by combination chemotherapy with and without irradiation in small-cell carcinoma of the bronchus. Thorax 38: 501-5,1983
Porte H, Metois D, Finzi L, Lebuffe G, Guidat A, Conti M, Wurtz A: Vena cava syndrome of malignant origin: Which surgical procedure for which diagnosis? Eur J Cardiothorac Surg Radiol 17: 384-8, 2000
Ali MK, Ewer MS, Balakrishnan PV, Ochoa OA, Morice RC, Raizner AE, Lawrie GM: Baloon angioplasty for Superior vena cava obstruction. Ann Int Med 107: 856-7,1987
Nicholson AA, Ettles DF, Arnold A, Greenstone M, Dyet JF: Treatment of malignant superior vena cava obstruction: Metal stents or radiation therapy. J V